| Literature DB >> 31484394 |
Shraddha Pawar1, Ambalal Chaudhari2, Ratna Prabha3, Renu Shukla4, Dhananjaya P Singh5.
Abstract
Pyrrolnitrin (PRN) is a microbial pyrrole halometabolite of immense antimicrobial significance for agricultural, pharmaceutical and industrial implications. The compound and its derivatives have been isolated from rhizospheric fluorescent or non-fluorescent pseudomonads, Serratia and Burkholderia. They are known to confer biological control against a wide range of phytopathogenic fungi, and thus offer strong plant protection prospects against soil and seed-borne phytopathogenic diseases. Although chemical synthesis of PRN has been obtained using different steps, microbial production is still the most useful option for producing this metabolite. In many of the plant-associated isolates of Serratia and Burkholderia, production of PRN is dependent on the quorum-sensing regulation that usually involves N-acylhomoserine lactone (AHL) autoinducer signals. When applied on the organisms as antimicrobial agent, the molecule impedes synthesis of key biomolecules (DNA, RNA and protein), uncouples with oxidative phosphorylation, inhibits mitotic division and hampers several biological mechanisms. With its potential broad-spectrum activities, low phototoxicity, non-toxic nature and specificity for impacts on non-target organisms, the metabolite has emerged as a lead molecule of industrial importance, which has led to developing cost-effective methods for the biosynthesis of PRN using microbial fermentation. Quantum of work narrating focused research efforts in the emergence of this potential microbial metabolite is summarized here to present a consolidated, sequential and updated insight into the chemistry, biology and applicability of this natural molecule.Entities:
Keywords: Halometabolites; antifungal activity; applications; biochemistry; biosynthesis; pyrrolnitrin; spectral properties
Mesh:
Substances:
Year: 2019 PMID: 31484394 PMCID: PMC6769897 DOI: 10.3390/biom9090443
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Structural diversity of organohalogen secondary metabolites from various organisms inhabiting different habitats.
| Organohalogens | Bioactivity | Halogen Type and Number | Source; Habitat | Reference(s) |
|---|---|---|---|---|
|
| ||||
| 4-Chloroindole Ester | Plant growth promoting hormone | Cl (01) | [ | |
| 3-Chloroindole acetate | Plant hormone | Cl (01) | [ | |
| Romucosine B | Plant alkaloids | Cl (01) | [ | |
| Neoirietetrao | Diterpene | Br (01) | [ | |
| Bromomethane | Fumigant; pesticides | Br (01) | Cabbage, Broccoli, Turnips, Rapeseeds (Family: | [ |
| 2-Chloro-4-Nitrophenol | Fungicide | Cl (01) | [ | |
|
| ||||
| Tyrosine derivative | Improving adhesion between protein fiber, sheets | Cl (01-03) | Marine Sponges, Sea fans, Gorgonians; | [ |
| Diiodotyrosine | Precursor in production of thyroid hormone | I (02) | [ | |
| Ecuadoran | Analgesic activity | Cl (01) | Epipedobotes; | [ |
| Tyrian Purple Dye | Dye | Br (02) | [ | |
| Drosophilin A | Antibiotic | Cl (04) | [ | |
| 2,6 Dichlorophenol | Sex pheromone; growth hormone | Cl (02) | [ | |
| 2,4 Dichlorophenol | Broad spectrum herbicides | Cl (02) | [ | |
| Epibatidine | Pain killer | Cl (01) | [ | |
|
| ||||
| Chloramphenicol | Antibiotic | Cl (02) | [ | |
| Chlortetracycline | Antibiotic | Cl (01) | [ | |
| Grisiofulvin | Antifungal drug | Cl (01) | [ | |
| Pyoluteorin | Antibiotic | Cl (02) | [ | |
| Fluoroacetic Acid | Pesticide | F (01) | [ | |
| Pyrrolnitrin | Antifungal antibiotic | Cl (02) | [ | |
| Nucleocidin | Nucleoside antibiotic | F (01) | [ | |
| Vancomycin | Antibiotic | Cl (02) | [ | |
| 2′Chloropentostatin | Nucleoside antibiotic | Cl (01) | [ | |
| Napyradiomycin | Antibiotic | Cl (02) | [ | |
| Calicheamicin Β1 | Cytotoxin | Br (01) | [ | |
| Pyrroindomycine B | Antibiotic | Cl (01) | [ | |
| Pentabromopseudilin | Marine antibiotic | Br (05) | [ | |
| Cryptophycin A | Anticancer | Cl (01) | [ | |
| 2-Chloro-4-Nitrophenol | Fungicide | Cl (01) | [ | |
| 3,5 Dichloro-Hexanophenone | Inhibit fruiting body formation | Cl (02) | [ | |
| Rebeccamycin | Weak Topoisomerase I Inhibitor, antitumor | Cl (02) | [ | |
| Chlortetracycline | Antibiotic | Cl (01) | [ | |
Figure 1Biosynthetic steps in the synthesis of pyrrolnitrin. 7-chlorotryptophan is formed from tryptophan due to flavin-dependent halogenation catalyzed by the enzyme tryptophan 7-halogenase (PrnA). Further, the enzyme PrnB (monodechloroaminopyrrolnitrin synthase catalyzes formation of monodechloroaminopyrrolnitrin from 7-chlorotryptophan while the enzyme PrnC leads to catalytic reaction for the conversion of monodechloroaminopyrrolnitrin into aminopyrrolnitrin. In the last step, aminopyrrolnitrin is converted to pyrrolnitrin with the help of the enzyme PrnD (aminopyrrolnitrin oxygenase).
Derivatives of pyrrolnitrin biosynthesized by Pseudomonas aureofaciens [56].
| IUPAC Name | Common Name | Structure | Extinction Coefficient ƛmax MeOH (log ε) | Molecular Formula | Molar Mass/ Molecular Weight | |
|---|---|---|---|---|---|---|
| 3-(2-amino-3-chlorophenyl)-pyrrole | Mono-chloro-amino-pyrrolnitrin (MCA) |
| - | 303 (3.52) |
| |
| 3-chloro-4(2-amino-3-chlorophenyl)-pyrrole | Di-chloro-amino (DCA) |
| 212 (4.46) | 302 (3.57) |
| |
| 2, 3 dichloro-4-(2-amino-3-chlorophenyl)-pyrrole | Tri-chloro-amino |
| 212 (4.54) | 302 (3.61) |
| |
| 3-chloro-4-(3-chloro-2nitro-phenyl)-1H pyrrole | Pyrrolnitrin (PRN) |
| 212 (4.39) | 252 (3.83) |
| |
| 2, 3 dichloro-4-(2-nitro-3-chlorophenyl) pyrrole | 2-chloro-pyrrolnitrin |
| 212 (4.47) | 240 |
| |
| 2-(2-Heptenyl)-3-methyl-4(1H) quinolone | - |
| - | - |
| |
| 2,3-dichloro-4-(2-nitrophenyl) pyrrole | Iso-pyrrolnitrin |
| - | - |
| |
| 3-chloro-4-(2-nitro-3-chloro-6-hydroxyphenyl) pyrrole | Oxy-pyrrolnitrin |
| - | - |
| |
Characteristics of PRN production by different microbial species inhabiting several ecohabitats.
| Sr. no. | Producer | Habitat | Medium | Physical Condition | Incubation Period (Days) | Concentration | Significance | Reference |
|---|---|---|---|---|---|---|---|---|
| 1. |
| - | Bouillon Medium | - | - | ND | Antibiotic, antifungal nature | [ |
| 2. |
| - | CMM, Synthetic C, E | 27 °C, shaker | 7 | 0.32–126 (µg mL−1) | PRN widespread in groups of | [ |
| 3. |
| - | CMM | 27 °C, shaker | 5 | 9.5 to 50 (µg mL−1) | Production of substituted PRN from Tryptophan analogs | [ |
| 4. |
| - | CMM | 30 °C, shaker | 5 | 18.35–19.9 (µm) | Possible pathway discussed | [ |
| 5. | Rhizosphere | Sabouraud Maltose Broth | - | 6 | 2.133 (mg L−1) | Efficacy against | [ | |
| 6. | Apple leaves | Mineral Salt, Nutrient Broth, Kings medium B | 27 °C, 200 rpm | 7 | 1) MS: 51.50 (mg L−1) 2) NB: 7.20 (mg L−1) 3) KMB: 5.50 (mg L−1) | Production of phenylpyrrole metabolites with respect to time | [ | |
| 7. |
| - | Mineral Salt | 27 °C, shaker | 7 | ND | Delays postharvest fruit rot in strawberries | [ |
| 8. | Grapes rhizosphere | Potato Dextrose Agar | Incubated on agar plate | 5 | ND | Possible role of a combination of Chitinases and pyrrolnitrin in antagonism | [ | |
| 9. | Ponds in botanical garden of Tubingen, Germany | Minimal medium | 27 °C, aeration rate 0·5 vvm, stirrer speed 150 rev min−1, pH −7.0 | 5 | 0.54 (mg L−1) | PRN block ETS | [ | |
| 10. | Soil sample, North Carolina | Nutrient broth, Mineral salt | 25 °C, at 200 rpm, pH 5.8 | 5 | NB: 35.59; MS: 28.54 (mg 1012 cfu) | Biocontrol of | [ | |
| 11. | Roots of | Standard succinate medium (SSM) | - | - | ND | Biocontrol property of plants protected from strain | [ | |
| 12. | - | Nutrient broth, Mung bean medium | 28 °C 200 rpm | - | 1.7 (µg mL−1) | Regulation by glucose of PRN production influenced biocontrol of tomato leaf blight | [ | |
| 13. | Wheat rhizosphere | Luria broth | - | 2 | 15 (mg L−1) | Plasmid-mediated pyrrolnitrin production by | [ | |
| 14. |
| - | M9 medium + 1 mm MgSO4 + 0.2% glucose | - | 5 | ND | Nematicidal and repellent activity against | [ |
| 15. | Tea rhizosphere | Semi-solid pigment producing media | 30 °C | 8 | ND | Effective reduction of root-rot disease tea plant on talc-based formulations; Plant growth promoting activity | [ |
CMM: Citrate minimal medium; ND: not determined; NB: Nutrient broth; MS; Murashige-Skoog medium; cfu: colony forming units; KMB: King’s medium-B.
Purification of pyrrolnitrin using various separation techniques with different solvent systems.
| Matrix | Column | Organic Phase | Detection | Reference |
|---|---|---|---|---|
| Silica gel G | 35 cm × 1.5 cm | Chloroform: methanol (9:1) | - | [ |
| Silica gel (40 μm) | 35.6 cm × 1.75 cm | Benzene: hexane (2:1); Benzene; Benzene: acetone (1:1); Acetone; methanol | TLC - bioautography | [ |
| Silica gel (60 μm) | - | Chloroform: hexane (1:1, 1.5:1, 2:1, 5:1) ( | Bioassay with | [ |
| Sephadex LH-20 | - | Methanol | pHPLC | [ |
| Silica gel 60 (0.015–0.040 mm; Merck) | - | Dichloromethane then methanol | TLC | [ |
| Silica gel (H60) | - | Dichloromethane | Bioautography | [ |
| Silica gel | (20 × 170 mm, Wakogel C-200) | Benzene, 10% ethyl acetatobenzene, 20% ethyl acetate benzene and finally ethyl acetate | TLC | [ |
| Silicic acid | (240 × 22 mm) | Diethyl ether and methanol | - | [ |
| - | RP C-18 flash | Water and methanol | TLC | [ |
| - | RP C-18 (MPLC) | 50% to 100% aq methanol | HPLC | [ |
| Silica gel (60 μm) | - | Toluene | - | [ |
TLC: thin layer chromatography; HPLC: high performance liquid chromatography; Aq.: Aqueous; MPLC: medium pressure liquid chromatography; RP: Reverse phase; pHPLC: preparative HPLC.
Several HPLC methods adopted to separate and quantify pyrrolnitrin from microbes using different solvent system.
| Column | Flow Rate (mL/min−1) | Solvent System | Detector | Retention Time (min) | References |
|---|---|---|---|---|---|
| RP 18 | 2 | Methanol: water (70:30; | - | - | [ |
| 50 mm × 4.6 mm I.D. guard | 1.0 | Acetonitrile: methanol: water (1:1:1) | UV (254 nm) | 10 | [ |
| Rainin Dynamax C18 (21.4 × 250 mm) | - | Acetonitrile: water (3:2; | - | 13.5 | [ |
| C-18 column, 5 µm | - | Isocratic acetonitrile: methanol: water (1:1:1) | - | - | [ |
| Hypersil octyldecyl saline (2.1 mm diameter by 10 cm) | - | Water: methanol from 0%: 100 % and gradually changing up to 100%: 0% | - | between 10-15 | [ |
| Reverse phase 18 | 0.7 | 0 min 50% methanol in water | UV (252 nm) | 15.4 | [ |
| C-18 reverse phase (125 × 4.6 mm) | - | Methanol: water (70:30; | UV (252 nm) | - | [ |
| - | 1.0 | 2-min initialization at 10% ACN: 0.1% TFA; 20-min linear gradient to 100% ACN: 0.1% TFA | 990-photodiode array detector | - | [ |
| Nucleosil C-18 | Acetonitrile: water (20 to 100%) | - | 27.5 | [ | |
| RP C-18 column | 1.0 | Isocratically 45% water: 30% acetonitrile: 25% methanol | - | - | [ |
| C-18 RP column | 10% acetonitrile: water ( | - | 18 | [ | |
| - | - | 30 ~ 60% aq acetonitrile (for 70 min) | - | 68.9 | [ |
| Gemini C18 column (100 × 4.6 mm; 5mm particle diameter) | 1.0 | Isocratically 45% acetonitrile: 35% water: 20% methanol | Dionex AD20 (Dionex,Sunnyvale, CA) (225 nm) | - | [ |
| Cosmosil C18 | 0.7 | 18 min linear gradient from 50 to 100% methanol and 0.1% trifluoracetic acid in methanol | - | - | [ |
Figure 2Cluster organization of pyrrolnitrin biosynthetic genes in Serratia plymuthica PR1-2C (1), Pseudomonas protegens Pf5 (2), Burkholderia pyrrocinia (3) and myxobacterium Melittangium boletus (4). Nucleotide sequence (NT size indicated for prnA–D genes) of the bacterial species was obtained from KEGG database.
Bioactivity spectrum of pyrrolnitrin against bacteria, fungi and nematodes.
| Sr. No. | Name of Test Microorganism | PRN (µg mL−1) | Reference |
|---|---|---|---|
|
| |||
| 1. | 6.2 | [ | |
| 2. |
| 250 | [ |
| 3. | 4.0 | [ | |
| 4. | 8.0 | [ | |
| 5. | 16.0 | [ | |
| 6. | >16.0 | [ | |
| 7. | >16.0 | [ | |
|
| |||
| 8. |
| 1.0 | [ |
| 9. |
| 10.0 | [ |
| 10. |
| < 0.78 | [ |
| 11. |
| 12.5 | [ |
| 12. |
| 0.78 | [ |
| 13. |
| 10.0 | [ |
|
| |||
| 14. |
| 0.05 | [ |
| 15. |
| < 0.78 | [ |
| 16. |
| 10.0 | [ |
| 17. |
| 10.0 | [ |
| 18. |
| 3.12 | [ |
| 19. |
| < 0.78 | [ |
| 20. |
| 0.156 | [ |
| 21. |
| 0.01 | [ |
| 22. |
| 50 (µg/disc) | [ |
|
| |||
| 23. |
| 0.1 | [ |